Stress granules (SGs) are membraneless organelles that form in response to cellular stress, sequestering translationally stalled mRNAs and associated proteins. These dynamic cytoplasmic assemblies represent a fundamental cellular protection mechanism, allowing cells to conserve resources and prioritize stress response programs during challenging conditions. Dysregulated stress granule dynamics have emerged as a critical pathological feature in amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
This page provides comprehensive coverage of stress granule biology, their role in neurodegeneration, molecular mechanisms, and therapeutic implications for neurodegenerative diseases.
| Property |
Value |
| Type |
Membraneless organelle, biomolecular condensate |
| Formation Trigger |
Cellular stress (oxidative, heat, viral, ER) |
| Core Components |
mRNA, ribonucleoproteins, translation initiation factors |
| Size |
0.1-5 μm diameter |
| Dynamics |
Liquid-liquid phase separation, reversible assembly |
| Disease Relevance |
ALS, FTD, AD, PD, Huntington's disease |
Stress granules are formed through a process known as liquid-liquid phase separation (LLPS), whereby proteins and RNAs coalesce into distinct liquid-like droplets that are distinct from the surrounding cytoplasm. This phase transition is driven by multivalent interactions between RNA-binding proteins (RBPs) containing intrinsically disordered regions (IDRs) and RNA molecules.
¶ G3BP1/G3BP2 (Ras-GAP SH3-domain-binding proteins)
- Function: Primary SG nucleators
- Role: Form the scaffold for SG assembly
- Domain structure: Multiple RNA-binding domains, IDR
- Phosphorylation: Regulates SG formation
- Disease mutations: ALS-associated G3BP1/2 mutations affect SG dynamics
- Function: SG assembly promotion
- Role: Facilitates recruitment of mRNAs and proteins
- Alternative splicing: TIA-1 and TIA1R variants
- Pathology: TIA-1 positive inclusions in ALS/FTD
- Function: Alternative splicing regulation
- Role: Complements TIA-1 in SG formation
- Mutations: Associated with Welander distal myopathy
¶ eIF4E and eIF4G
- Function: mRNA cap-binding complex
- Role: Sequestered in SGs during stress
- Significance: Translation arrest mechanism
- Function: Met-tRNAiMet delivery to ribosome
- Phosphorylation: Key SG formation trigger
- Kinases: PERK, GCN2, PKR, HRI
- eIF2α-P: Drives translational arrest, SG assembly
- Normal function: RNA splicing, transport, translation
- SG localization: Recruited to SGs under stress
- Pathology: Cytoplasmic inclusions in ALS/FTD
- Aggregation: Loss of nuclear function, toxic gain-of-function
- Normal function: RNA processing, DNA repair
- SG association: Dynamically localizes to SGs
- Mutations: ALS-causing FUS mutations alter SG dynamics
- Liquid-liquid phase separation: FUS mutations affect LLPS
- Function: Pre-mRNA processing, splicing
- SG components: Found in stress-induced granules
- Mutations: Associated with ALS and inclusion body myopathy
- Function: Rab GTPase regulation, autophagy
- Pathology: Hexanucleotide repeat expansion in ALS/FTD
- SG effects: Dipeptide repeats disrupt SG dynamics
- Mechanisms: Arginine-rich DPRs co-localize with SG proteins
- Translationally stalled mRNAs: Primary SG components
- mRNA turnover: SG as temporary storage
- Selected mRNAs: Specific transcripts preferentially targeted
- MicroRNAs: Sequestered in SGs
- Small nucleolar RNAs: Some SG associations
- Regulatory roles: SG as regulatory platform
¶ Biogenesis and Dynamics
¶ Stress Sensing and Initiation
- Stress detection: Cellular stress sensors activated
- eIF2α phosphorylation: Global translation arrest
- mRNA accumulation: Untranslated mRNAs accumulate
- Nucleation: G3BP1/2 initiate SG assembly
- Multivalent interactions: Protein-RNA interactions drive condensation
- Intrinsically disordered regions: Low-complexity domains promote LLPS
- Saturation concentration: Concentration-dependent formation
- Surface tension: Determines droplet size and fusion
¶ Maturation and Aging
- Initial formation: Dynamic, liquid-like droplets
- Aging: Can transition to more solid-like states
- 凝胶化 (Gelation): Pathological conversion to solid aggregates
- Implications: Aging SGs may become irreversible
- eIF2α dephosphorylation: Restores translation
- Molecular chaperones: Promote disassembly
- ATP-dependent processes: Energy requirements
- Macroautophagy: Bulk SG clearance
- Selective autophagy: Specific SG component degradation
- Licensing: Ubiquitination marks SGs for clearance
- NBR1: Selective autophagy receptor for SGs
- 40S and 60S subunits: Released and recycled
- Translation restart: Normal protein synthesis resumes
- Quality control: Damaged mRNAs degraded
- Energy conservation: Reduces ATP consumption
- Prioritization: Focus resources on stress response proteins
- mRNA protection: Shields mRNAs from degradation
- Signaling compartmentalization: Isolates signaling components
- Kinase/phosphatase balance: Modulates signaling pathways
- Activation threshold: Modulates stress response sensitivity
- Aggregation prevention: Provides alternative to protein aggregation
- Chaperone recruitment: Molecular chaperones localize to SGs
- Clearance pathways: Links to autophagy and proteasome
- Temporary sequestration: Stores mRNAs for later use
- mRNA surveillance: Quality control platform
- Translation repression: Reversible regulation
- Splicing regulation: Alternative splicing modulation
- Transport: May affect mRNA localization
- Decay: Links to mRNA degradation pathways
- Cytoplasmic inclusions: Hallmark of 95% of ALS cases
- SG origin: TDP-43 inclusions derived from stress granules
- Loss of function: Nuclear TDP-43 depletion
- Gain of toxicity: Cytoplasmic aggregates are toxic
- Cytoplasmic FUS: Present in subset of ALS cases
- SG disruption: FUS mutations alter SG dynamics
- Phase separation: Mutations affect LLPS properties
- Nucleocytoplasmic transport: FUS in nuclear pore function
- Hexanucleotide repeats: Most common genetic cause of ALS/FTD
- Dipeptide repeat proteins: Toxic arginine-rich DPRs
- SG sequestration: DPRs sequester SG proteins
- Stress hypersensitivity: Cells more vulnerable to stress
- SG modulators: Targeting SG dynamics
- Autophagy enhancers: Promote SG clearance
- Phase separation inhibitors: Prevent pathological transitions
- Overlap with ALS: Common pathological features
- SG dynamics: Similar mechanisms as ALS
- Specific brain regions: Frontal and temporal cortex affected
- FUS pathology: Distinct from TDP-43 FTD
- SG involvement: FUS-positive inclusions
- Atypical clinical features: Behavioral variant FTD
- Co-localization: Tau pathology associates with SG proteins
- eIF2α phosphorylation: Elevated in AD brain
- Translational dysregulation: Global translation impairment
- Amyloid-β toxicity: Enhances SG formation
- Synaptic stress: SGs form at synapses under stress
- Memory impairment: SG persistence may affect cognition
- Co-aggregation: α-syn with SG proteins
- Stress sensitivity: PD neurons show enhanced SG formation
- Autophagy impairment: Defective SG clearance
- Kinase activity: LRRK2 mutations increase SG formation
- Ribophagy: LRRK2 regulates selective autophagy
- Therapeutic targeting: LRRK2 inhibitors may affect SG dynamics
- Transcriptional dysregulation: Affects SG protein expression
- Stress hypersensitivity: Enhanced SG formation
- RNA binding: HTT interacts with SG proteins
- SG modulators: Potential therapeutic approach
- Autophagy enhancement: Promote clearance of SG-associated protein aggregates
- Failure to resolve: SGs become persistent
- Aging and solidification: Liquid-to-solid transition
- Aggregate formation: Irreversible protein aggregates
- Essential RBPs: Sequestered in pathological SGs
- Loss of function: Nuclear function loss
- RNA metabolism disruption: Altered post-transcriptional regulation
- Autophagy saturation: Clearance pathways overwhelmed
- Proteasome inhibition: Ubiquitinated proteins accumulate
- Aggregate accumulation: Pathological protein deposits
¶ Nuclear Pore and Transport
- Nuclear pore components: SG proteins affect pore function
- Importin dysregulation: Altered nuclear import/export
- Nuclear envelope stress: Contributes to neurodegeneration
- Alternative splicing: Altered by SG protein loss
- Toxic splicing: Aberrant mRNA isoforms produced
- Nonsense-mediated decay: Links to SG function
- Global impairment: Chronic translation suppression
- Specific mRNAs: Altered translation of key proteins
- Synaptic protein loss: Contributes to synaptic dysfunction
- eIF2α dephosphorylation: ISRIB (integrated stress response inhibitor)
- PERK inhibitor: Reduces ER stress-induced SG formation
- GSK3β inhibition: Modulates SG dynamics
- Small molecule modulators: In development
- Lipid modulators: Membrane-associated regulation
- Molecular tweezers: Disrupt protein-protein interactions
- mTOR inhibition: Rapamycin promotes autophagy
- Autophagy activators: Small molecule inducers
- NBR1 targeting: Enhance selective SG clearance
- Antisense oligonucleotides: Target toxic protein expression
- RNAi: Knockdown of disease proteins
- CRISPR: Gene editing approaches
- Overexpression of chaperones: Enhance SG resolution
- Modulating SG nucleators: G3BP1/2 manipulation
- RNA-based therapeutics: Target SG-associated RNAs
- Lithium: Modulates SG dynamics via GSK3
- Trehalose: Autophagy enhancer, SG clearance
- Sodium valproate: HDAC inhibitor, affects SG
¶ Detection and Visualization
- SG markers: G3BP1, TIA-1, TDP-43
- Confocal microscopy: Subcellular localization
- Live cell imaging: SG dynamics in real-time
- Fractionation: SG enrichment protocols
- Mass spectrometry: Proteomic analysis
- RNA sequencing: SG-associated RNA profiling
- Neuronal cell lines: SH-SY5Y, PC12, primary neurons
- iPSC-derived neurons: Patient-specific models
- Stress treatments: Oxidative, heat shock, ER stress
- Transgenic mice: SG protein mutant models
- C. elegans: Simple model of SG formation
- Drosophila: Genetic models of neurodegeneration
The study of Stress Granule Formation In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Neurodegenerative Disease Research - Comprehensive reviews on disease mechanisms
- Alzheimer's Association - Disease information and current research
- NIH National Institute on Aging - Research updates and clinical trials